Patents/Assignees

Modernatx, Inc.

95 patents in portfolio

US12403336utility2025
Betacorona Virus Mrna Vaccines
0 cites
US12403335utility2025
Betacoronavirus MRNA Vaccines
0 cites
US12396961utility2025
Compounds and Compositions for Intracellular Delivery of Agents
0 cites
US12383508utility2025
High-purity Peg Lipids and Uses Thereof
0 cites
US12385034utility2025
Methods and Apparatus for Filtration
0 cites
US12364763utility2025
Delivery and Formulation of Engineered Nucleic Acids
0 cites
US12357575utility2025
Methods of Making Lipid Nanoparticles
0 cites
US12357708utility2025
Modified Nucleosides, Nucleotides, and Nucleic Acids, and Uses Thereof
0 cites
US12329812utility2025
Nucleic Acid Vaccines
0 cites
US12329811utility2025
Seasonal RNA Influenza Virus Vaccines
0 cites
US12324859utility2025
Compounds and Compositions for Intracellular Delivery of Therapeutic Agents
0 cites
US12318443utility2025
Influenza Vaccine
0 cites
US12312293utility2025
Branched Tail Lipid Compounds and Compositions for Intracellular Delivery of Therapeutic Agents
0 cites
US12274743utility2025
Nucleic Acid Vaccines
0 cites
US12263248utility2025
Compounds and Compositions for Intracellular Delivery of Therapeutic Agents
0 cites
US12252704utility2025
Polynucleotides Encoding Galactose-1-phosphate Uridylyltransferase for the Treatment of Galactosemia Type 1
0 cites
US12246029utility2025
High Purity RNA Compositions and Methods for Preparation Thereof
0 cites
US12246030utility2025
Methods for Therapeutic Administration of Messenger Ribonucleic Acid Drugs
0 cites
US12239742utility2025
Polynucleotides Encoding Citrin for the Treatment of Citrullinemia Type 2
0 cites
US12241063utility2025
Modified Messenger RNA Comprising Functional RNA Elements
0 cites

← PreviousPage 2 of 5Next →